Risk of second primary colorectal cancer among colorectal cancer cases: A population-based analysis

Journal of Carcinogenesis

Volumn 10, Issue , 2011, Pages

  Raj, Kavitha ^a   Taylor, Thomas ^a   Wray, Charlie ^b   Stamos, Michael ^c   Zell, Jason ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b WESTERN UNIVERSITY OF HEALTH SCIENCES   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cancer registry; colon cancer; colorectal cancer; rectal cancer; second primary cancer

Indexed keywords

ADULT; AGED; ARTICLE; ASCENDING COLON; CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER REGISTRY; CANCER SURGERY; CANCER SURVIVOR; COHORT ANALYSIS; COLORECTAL CANCER; DESCENDING COLON; FEMALE; FOLLOW UP; HISPANIC; HUMAN; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; SECOND CANCER; SECOND PRIMARY COLORECTAL CANCER; SEX DIFFERENCE;

EID: 82455221425     PISSN: 09746773     EISSN: 14773163     Source Type: Journal    
DOI: 10.4103/1477-3163.78114     Document Type: Article

References (55)

1. Jemal A, Siegel R, Xu J, Ward E. Cancer statistics. CA Cancer J Clin 2010;60:277-300.
2. National Center for Health Statistics. Estimates of the July 1, 2000-July 1, 2005, United States resident population from the Vintage 2005 postcensal series by year, county, age, sex, race, and Hispanic origin, prepared under a collaborative arrangement with the U.S. Census Bureau. 2006:Available on the Internet from: http://www.cdc.gov/nchs/about/major/dvs/popbridge/popbridge.htm.
3. Muller AD, Sonnenberg A. Prevention of Colorectal Cancer by Flexible Endoscopy and Polypectomy: A Case-Control Study of 32 702 Veterans. Ann Intern Med 1995;123:904-10.
4. Rex DK, Kahi CJ, Levin B, Smith RA, Bond JH, Brooks D, et al. Guidelines for Colonoscopy Surveillance after Cancer Resection: A Consensus Update by the American Cancer Society and US Multi-Society Task Force on Colorectal Cancer. CA Cancer J Clin 2006;56:160-7. (Pubitemid 43847926)
5. Winawer SJ, Zauber AG, Ho MN, O'Brien MJ, Gottlieb LS, Sternberg SS, et al. Prevention of Colorectal Cancer by Colonoscopic Polypectomy. N Engl J Med 1993;329:1977-81. (Pubitemid 24015040)
6. National Comprehensive Cancer Network Practice Guidelines in Oncology, http://www.nccn.org. 2010:v.1.2011.
7. Enblad P. The Risk of Subsequent Primary Malignant Diseases After Cancer of the Colon and Rectum. Cancer 1990;65:2091-100. (Pubitemid 20147654)
8. Hemminki K, Li X, Dong C. Second Primary Cancers after Sporadic and Familial Colorectal Cancer. Cancer Epidemiol Biomarkers Prev 2001;10:793-8. (Pubitemid 32695159)
9. Green RJ, Metlay JP, Propert K, Catalano PJ, Macdonald JS, Mayer RJ, et al. Surveillance for second primary colorectal cancer after adjuvant chemotherapy: An analysis of Intergroup 0089. Ann Intern Med 2002;136:261-9. (Pubitemid 34150755)
10. Cunliffe WJ, Hasleton PS, Tweedle DE, Schofield PF. Incidence of synchronous and metachronous colorectal carcinoma. Br J Surg 1984;71:941-3. (Pubitemid 15218312)
11. Lockhart-Mummery HE, Heald RJ. Metachronous cancer of the large intestine. Dis Colon Rectum 1972;15:261-4.
12. Yamazaki T, Takii Y, Okamoto H, Sakai Y, Hatakeyama K. What is the risk factor for metachronous colorectal carcinoma? Dis Colon Rectum 1997;40:935-8. (Pubitemid 27355396)
13. Carlsson G, Petrelli NJ, Nava H, Herrera L, Mittelman A. The value of colonoscopic surveillance after curative resection for colorectal cancer or synchronous adenomatous polyps. Arch Surg 1987;122:1261-3. (Pubitemid 18021279)
14. Chen F, Stuart M. Colonoscopic follow-up of colorectal carcinoma. Dis Colon Rectum 1994;37:568-72. (Pubitemid 24180778)
15. Olsen HW, Lawrence WA, Snook CW, Mutch WM. Review of recurrent polyps and cancer in 500 patients with initial colonoscopy for polyps. Dis Colon Rectum 1988;31:222-7. (Pubitemid 18096401)
16. Granqvist S, Karlsson T. Postoperative follow-up of patients with colorectal carcinoma by colonoscopy. Eur J Surg 1992;158:307-12.
17. Curtis FD, Ron E, Ries LA, Hacker DG, Edwards BK, Tucker MA, et al. New Malignancies Among Cancer Survivors: SEER Cancer Registries, 1973-2000. In: National Cancer Institute. Bethesda, MD: NIH Publication; 2006.
18. Smith RA, Cokkinides V, Brawley OW. Cancer Screening in the United States, 2008: A Review of Current American Cancer Society Guidelines and Cancer Screening Issues. CA Cancer J Clin 2008;58:161-79. (Pubitemid 351830300)
19. Ward E, Jemal A, Cokkinides V, Singh GK, Cardinez C, Ghafoor A, et al. Cancer Disparities by Race/Ethnicity and Socioeconomic Status. CA Cancer J Clin 2004;54:78-93. (Pubitemid 38519418)
20. Le H, Ziogas A, Lipkin SM, Zell JA. Effects of socioeconomic status and treatment disparities in colorectal cancer survival. Cancer Epidemiol Biomarkers Prev 2008;17:1950-62.
21. Wray CM, Ziogas A, Hinojosa MW, Le H, Stamos MJ, Zell JA. Tumor subsite location within the colon is prognostic for survival after colon cancer diagnosis. Dis Colon Rectum 2009;52:1359-66.
22. Percy VH, Muir C. International Classification of Diseases for Oncology. 2nd ed. Geneva: World Health Organization; 1990.
23. Surveillance, Epidemiology, and End Results Program. SEER site recode icd-o-2 (4/15/2002) definition. Bethesda, MD: National Cancer Institute 2002.
24. California Cancer Registry, Cancer Surveillance Section. Cancer reporting in California: data standards for regional registries and California cancer registry California cancer reporting system standards, vol III. Sacramento, CA: California Department of Health Services 2003.
25. Taylor TH, Bringman D, Anton-Culver H. Malignancies following in situ cervical cancer in Hispanic Americans and non-Hispanic Whites. Gynecol Oncol 2006;103:1012-6. (Pubitemid 44822623)
26. Bessonova L, Taylor TH, Mehta RS, Zell JA, Anton-Culver H. Risk of a Second Breast Cancer Associated with Hormone-Receptor and HER2/neu Status of the First Breast Cancer. Cancer Epidemiol Biomarkers Prev 2011;20:389-96.
27. Esteve BE, Raymond L. Statistical methods in cancer research, Descriptive epidemiology. New York: Oxford University Press 1994;4.
28. Mulder PGH. An exact method for calculating a confidence interval of a poisson parameter. Am J Epidemiol 1983;117:377.
29. Armitage P. Tests for linear trends in proportions and frequencies. Biometrics 1955;11:375-86.
30. Agretsi A. An introduction to categorical data analysis. New York: Wiley; 1996.
31. Das A, Chak A, Cooper GS. Temporal trend in relative risk of second primary colorectal cancer. Am J Gastroenterol 2006;101:1342-7. (Pubitemid 43830003)
32. Weisenberger DJ, Siegmund KD, Campan M, Young J, Long TI, Faasse MA, et al. CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer. Nat Genet 2006;38:787-93. (Pubitemid 43980599)
33. Azzoni C, Bottarelli L, Campanini N, Di G, Bader G, Mazzeo A, et al. Distinct molecular patterns based on proximal and distal sporadic colorectal cancer: Arguments for different mechanisms in the tumorigenesis. Int J Colorectal Dis 2007;22:115-26. (Pubitemid 44964014)
34. Baxter NN, Goldwasser MA, Paszat LF, Saskin R, Urbach DR, Rabeneck L. Association of colonoscopy and death from colorectal cancer. Ann Intern Med 2009;150:1-8.
35. Ransohoff DF. How much does colonoscopy reduce colon cancer mortality? Ann Intern Med 2009;150:50-2.
36. Grodstein F, Newcomb PA, Stampfer MJ. Postmenopausal hormone therapy and the risk of colorectal cancer: A review and meta-analysis. Am J Med 1999;106:574-82. (Pubitemid 29231110)
37. Newcomb PA, Storer BE. Postmenopausal hormone use and risk of large-bowel cancer. J Natl Cancer Inst 1995;87:1067-71.
38. Liang W. Age, sex and the risk of grade-specific second primary colorectal cancer: Evidence for the protective effect of female hormone. Eur J Cancer 2007;43:1856-61. (Pubitemid 47238249)
39. Chlebowski RT, Wactawski-Wende J, Ritenbaugh C, Hubbell FA, Ascensao J, Rodabough RJ, et al. Estrogen plus progestin and colorectal cancer in postmenopausal women. N Engl J Med 2004;350:991-1004. (Pubitemid 38269276)
40. Foley EF, Jazaeri AA, Shupnik MA, Jazaeri O, Rice LW. Selective loss of estrogen receptor beta in malignant human colon. Cancer Res 2000;60:245-8. (Pubitemid 30070743)
41. Walsh JM, Kaplan CP, Nguyen B, Gildengorin G, McPhee SJ, Perez-Stable EJ. Barriers to colorectal cancer screening in Latino and Vietnamese Americans. Compared with non-Latino white Americans. J Gen Intern Med 2004;19:156-66. (Pubitemid 38368464)
42. Green AR, Peters-Lewis A, Percac-Lima S, Betancourt JR, Richter JM, Janairo MP, et al. Barriers to screening colonoscopy for low-income Latino and white patients in an urban community health center. J Gen Intern Med 2008;23:834-40.
43. Fuchs CS, Giovannucci EL, Colditz GA, Hunter DJ, Speizer FE, Willett WC. A prospective study of family history and the risk of colorectal cancer. N Engl J Med 1994;331:1669-74. (Pubitemid 24373618)
44. Johns LE, Houlston RS. A systematic review and meta-analysis of familial colorectal cancer risk. Am J Gastroenterol 2001;96:2992-3003. (Pubitemid 32959544)
45. Potter JD, Slattery ML, Bostick RM, Gapstur SM. Colon cancer: a review of the epidemiology. Epidemiol Rev 1993;15:499-545. (Pubitemid 24072641)
46. Slattery ML, Kerber RA. Family history of cancer and colon cancer risk: The Utah Population Database. J Natl Cancer Inst 1994;86:1618-26. (Pubitemid 24336348)
47. Chan JA, Meyerhardt JA, Niedzwiecki D, Hollis D, Saltz LB, Mayer RJ, et al. Association of family history with cancer recurrence and survival among patients with stage III colon cancer. JAMA 2008;299:2515-23. (Pubitemid 351787207)
48. Zell JA, Honda J, Ziogas A, Anton-Culver H. Survival after colorectal cancer diagnosis is associated with colorectal cancer family history. Cancer Epidemiol Biomarkers Prev 2008;17:3134-40.
49. Peel DJ, Ziogas A, Fox EA, Gildea M, Laham B, Clements E, et al. Characterization of hereditary nonpolyposis colorectal cancer families from a population-based series of cases. J Natl Cancer Inst 2000;92:1517-22.
50. Ganz PA. A teachable moment for oncologists: cancer survivors, 10 million strong and growing! J Clin Oncol 2005;23:5458-60.
51. Mariotto AB, Rowland JH, Ries LA, Scoppa S, Feuer EJ. Multiple cancer prevalence: A growing challenge in long-term survivorship. Cancer Epidemiol Biomarkers Prev 2007;16:566-71. (Pubitemid 46548662)
52. Chu DZ, Chansky K, Alberts DS, Meyskens FL, Fenoglio-Preiser CM, Rivkin SE, et al: Adenoma Recurrences After Resection of Colorectal Carcinoma: Results From the Southwest Oncology Group 9041 Calcium Chemoprevention Pilot Study. Ann Surg Oncol 2003;10:829-30.
53. S0820, "A double-blind placebo-controlled trial of eflornithine and sulindac to prevent recurrence of high risk adenomas and second primary colorectal cancers in patients with stage 0-III colon cancer." Southwest Oncology Group Fall 2009 Group Meeting Agenda Available from: http://www.swog.org/Visitors/Fall09GpMtg/0910Agenda.pdf, page 0937. [accessed on 2010 Feb 1].
54. 80702 "A phase III trial of 6 versus 12 treatments of adjuvant FOLFOX with or without celecoxib therapy for patients with stage III colon cancer". Cancer and Leukemia Group B Summer 2009 Agenda Book. Available from: http://www.calgb.org/Public/meetings/meeting-documents/2009/summer-group/ AgendaBook-062009.pdf, page 062007[accessed on 2010 Feb 1].
55. NSABP P-5, "Rosuvastatin in Treating Patients With Stage I or Stage II Colon Cancer That Was Removed By Surgery". ClinicalTrialsgov website. Available from: http://clinicaltrials.gov/ct2/show/NCT01011478. [accessed on 2010 Oct 18].